Atea Pharmaceuticals (AVIR) Prepaid Assets (2019 - 2026)
Atea Pharmaceuticals (AVIR) recorded quarterly Prepaid Assets of $7.2 million in Q1 2026, down 21.5% quarter-over-quarter from $9.2 million in Q4 2025, and down 13.07% on a YoY basis from $8.3 million in Q1 2025.
Atea Pharmaceuticals (AVIR) Prepaid Assets (2019 - 2026) Analysis & Trends
Atea Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $7.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 13.07% year-over-year to $7.2 million; the TTM figure through Mar 2026 stood at $7.2 million (down 13.07% YoY), while the FY2025 annual figure was $9.2 million, up 20.0% from the prior year.
- Prepaid Assets was $7.2 million for Q1 2026 at Atea Pharmaceuticals, down from $9.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $14.2 million in Q4 2022 to a low of $4.1 million in Q3 2024.
- Historically, Prepaid Assets has averaged $8.5 million across 5 years, with a median of $7.7 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 278.76% in 2022, then plunged 67.45% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $14.2 million in 2022, then decreased by 13.11% to $12.3 million in 2023, then sank by 38.18% to $7.6 million in 2024, then increased by 20.0% to $9.2 million in 2025, then declined by 21.5% to $7.2 million in 2026.
- The last three Prepaid Assets figures came in at $7.2 million (Q1 2026), $9.2 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Atea Pharmaceuticals | 347.28 Mn | 347.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.19 Mn |
| Dec 31, 2025 | 9.16 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Jun 30, 2025 | 5.89 Mn |
| Mar 31, 2025 | 8.27 Mn |
| Dec 31, 2024 | 7.63 Mn |
| Sep 30, 2024 | 4.09 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 7.27 Mn |
| Dec 31, 2023 | 12.35 Mn |
| Sep 30, 2023 | 8.19 Mn |
| Jun 30, 2023 | 12.76 Mn |
| Mar 31, 2023 | 11.90 Mn |
| Dec 31, 2022 | 14.21 Mn |
| Sep 30, 2022 | 12.45 Mn |
| Jun 30, 2022 | 4.97 Mn |
| Mar 31, 2022 | 7.69 Mn |
| Dec 31, 2021 | 8.03 Mn |
| Sep 30, 2021 | 3.29 Mn |
| Jun 30, 2021 | 4.65 Mn |